{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:33:23Z","timestamp":1793172803670,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T00:00:00Z","timestamp":1576540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008453","name":"Ontario Institute for Regenerative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000098","name":"Stem Cell Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EClinicalMedicine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.eclinm.2019.100249","type":"journal-article","created":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T05:33:35Z","timestamp":1579239215000},"page":"100249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":259,"special_numbering":"C","title":["Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis"],"prefix":"10.1016","volume":"19","author":[{"given":"Mary","family":"Thompson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley H.J.","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianna","family":"Wolfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9e","family":"Champagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Fergusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan J.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina J.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Doxtator","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Lalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane W.","family":"English","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Granton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Hutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alies","family":"Maybee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith R.","family":"Walley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia Dos","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent","family":"Winston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauralyn","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2019.100249_bib0001","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00007890-196803000-00009","article-title":"Heterotopic transplants of bone marrow","volume":"6","author":"Friedenstein","year":"1968","journal-title":"Transplantation"},{"key":"10.1016\/j.eclinm.2019.100249_bib0002","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/path.2469","article-title":"Why are MSCs therapeutic? New data: new insight","volume":"217","author":"Caplan","year":"2009","journal-title":"J Pathol"},{"key":"10.1016\/j.eclinm.2019.100249_bib0003","doi-asserted-by":"crossref","first-page":"S569","DOI":"10.1097\/CCM.0b013e3181f1ff1d","article-title":"Mesenchymal stem cells for acute lung injury: preclinical evidence","volume":"38","author":"Matthay","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.eclinm.2019.100249_bib0004","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1371\/journal.pmed.0040269","article-title":"Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1","volume":"4","author":"Mei","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.eclinm.2019.100249_bib0005","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1164\/rccm.201001-0010OC","article-title":"Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis","volume":"182","author":"Mei","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.eclinm.2019.100249_bib0006","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-1-60761-705-1_5","article-title":"Mesenchymal stem cell therapy for cardiac repair","volume":"660","author":"Boyle","year":"2010","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.eclinm.2019.100249_bib0007","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3109\/14653249.2010.507330","article-title":"Defining the risks of mesenchymal stromal cell therapy","volume":"12","author":"Prockop","year":"2010","journal-title":"Cytotherapy"},{"key":"10.1016\/j.eclinm.2019.100249_bib0008","doi-asserted-by":"crossref","first-page":"e47559","DOI":"10.1371\/journal.pone.0047559","article-title":"Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials","volume":"7","author":"Lalu","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.eclinm.2019.100249_bib0009","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the prisma statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eclinm.2019.100249_bib0010","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1089\/scd.2015.0329","article-title":"Effects of freeze-thawing and intravenous infusion on mesenchymal stromal cell gene expression","volume":"25","author":"Hoogduijn","year":"2016","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.eclinm.2019.100249_bib0011","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/stem.1111","article-title":"Are therapeutic human mesenchymal stromal cells compatible with human blood?","volume":"30","author":"Moll","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.eclinm.2019.100249_bib0012","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/07853890.2016.1157725","article-title":"Administration of bone marrow stromal cells in sepsis attenuates sepsis-related coagulopathy","volume":"48","author":"Tan","year":"2016","journal-title":"Ann Med"},{"key":"10.1016\/j.eclinm.2019.100249_bib0013","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.molmed.2018.12.006","article-title":"Intravascular mesenchymal stromal\/stem cell therapy product diversification: time for new clinical guidelines","volume":"25","author":"Moll","year":"2019","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.eclinm.2019.100249_bib0014","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/stem.2891","article-title":"Intravenous infusion of human adipose mesenchymal stem cells modifies the host response to lipopolysaccharide in humans: a randomized, single-blind, parallel group, placebo controlled trial","volume":"36","author":"Perlee","year":"2018","journal-title":"Stem Cells"},{"key":"10.1016\/j.eclinm.2019.100249_bib0015","doi-asserted-by":"crossref","first-page":"781","DOI":"10.7326\/0003-4819-141-10-200411160-00009","article-title":"Better reporting of harms in randomized trials: an extension of the consort statement","volume":"141","author":"Ioannidis","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eclinm.2019.100249_bib0016","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.eclinm.2019.100249_bib0017","series-title":"Cochrane handbook for systematic reviews of interventions. 5.1.0 ed.","author":"Higgins","year":"2011"},{"key":"10.1016\/j.eclinm.2019.100249_bib0018","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1465-9921-15-39","article-title":"Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study","volume":"15","author":"Zheng","year":"2014","journal-title":"Respir Res"},{"key":"10.1016\/j.eclinm.2019.100249_bib0019","article-title":"Administration of multipotent mesenchymal stromal cells (MSC) improves short term but not long term survival in oncohematological neutropenic patients (PTS) with septic shock (SS)","volume":"4","author":"Galstyan","year":"2016","journal-title":"Intensive Care Med Exp"},{"key":"10.1016\/j.eclinm.2019.100249_bib0020","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/annrheumdis-2015-208918","article-title":"Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib\/IIa clinical trial","volume":"76","author":"Alvaro-Gracia","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.eclinm.2019.100249_bib0021","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jcyt.2014.10.009","article-title":"Randomized, double-blind, phase I\/II study of intravenous allogeneic mesenchymal stromal cells in acute myocardial infarction","volume":"17","author":"Chullikana","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/j.eclinm.2019.100249_bib0022","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.2337\/dc14-2830","article-title":"Allogeneic mesenchymal precursor cells in type 2 diabetes: a randomized, placebo-controlled, dose-escalation safety and tolerability pilot study","volume":"38","author":"Skyler","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eclinm.2019.100249_bib0023","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1378\/chest.12-2094","article-title":"A placebo-controlled, randomized trial of mesenchymal stem cells in copd","volume":"143","author":"Weiss","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.eclinm.2019.100249_bib0024","first-page":"1443","article-title":"Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction","volume":"117","author":"Chen","year":"2004","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.eclinm.2019.100249_bib0025","first-page":"4","article-title":"Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomyopathy due to isolated chronic occluded left anterior descending artery","volume":"18","author":"Chen","year":"2006","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.eclinm.2019.100249_bib0026","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1016\/j.ijcard.2013.04.112","article-title":"A critical challenge: dosage-related efficacy and acute complication intracoronary injection of autologous bone marrow mesenchymal stem cells in acute myocardial infarction","volume":"168","author":"Gao","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.eclinm.2019.100249_bib0027","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/j.jacc.2009.06.055","article-title":"A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction","volume":"54","author":"Hare","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.eclinm.2019.100249_bib0028","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1507\/endocrj.EJ12-0343","article-title":"Long term effects of the implantation of Wharton's jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus","volume":"60","author":"Hu","year":"2013","journal-title":"Endocr J"},{"key":"10.1016\/j.eclinm.2019.100249_bib0029","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3346\/jkms.2014.29.1.23","article-title":"A randomized, open-label, multicenter trial for the safety and efficacy of adult mesenchymal stem cells after acute myocardial infarction","volume":"29","author":"Lee","year":"2014","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.eclinm.2019.100249_bib0030","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ana.23612","article-title":"A randomized trial of mesenchymal stem cells in multiple system atrophy","volume":"72","author":"Lee","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.eclinm.2019.100249_bib0031","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/sj.clpt.6100386","article-title":"Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy","volume":"83","author":"Lee","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.eclinm.2019.100249_bib0032","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/stem.430","article-title":"A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke","volume":"28","author":"Lee","year":"2010","journal-title":"Stem Cells"},{"key":"10.1016\/j.eclinm.2019.100249_bib0033","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1089\/scd.2010.0447","article-title":"Coinfusion of mesenchymal stromal cells facilitates platelet recovery without increasing leukemia recurrence in haploidentical hematopoietic stem cell transplantation: a randomized, controlled clinical study","volume":"20","author":"Liu","year":"2011","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.eclinm.2019.100249_bib0034","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/sj.leu.2405090","article-title":"The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study","volume":"22","author":"Ning","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.eclinm.2019.100249_bib0035","doi-asserted-by":"crossref","first-page":"725","DOI":"10.5966\/sctm.2012-0034","article-title":"Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients","volume":"1","author":"Shi","year":"2012","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.eclinm.2019.100249_bib0036","first-page":"2","article-title":"Curative effect of autologous mesenchymal stem cell transplantation on spinal cord injury","volume":"11","author":"Xie","year":"2007","journal-title":"J Clin Rehabil Tissue Eng Res"},{"key":"10.1016\/j.eclinm.2019.100249_bib0037","first-page":"107","article-title":"[A prospective, randomized, controlled trial of autologous mesenchymal stem cells transplantation for dilated cardiomyopathy]","volume":"34","author":"Wang","year":"2006","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"10.1016\/j.eclinm.2019.100249_bib0038","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/QAD.0b013e32835fab77","article-title":"Safety and immunological responses to human mesenchymal stem cell therapy in difficult-to-treat HIV-1-infected patients","volume":"27","author":"Zhang","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.eclinm.2019.100249_bib0039","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2337\/db14-0656","article-title":"Preserved beta-cell function in type 1 diabetes by mesenchymal stromal cells","volume":"64","author":"Carlsson","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.eclinm.2019.100249_bib0040","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12916-015-0399-z","article-title":"Intracoronary infusion of Wharton's jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial","volume":"13","author":"Gao","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.eclinm.2019.100249_bib0041","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1134\/S0006297914120104","article-title":"Analysis of results of acute graft-versus-host disease prophylaxis with donor multipotent mesenchymal stromal cells in patients with hemoblastoses after allogeneic bone marrow transplantation","volume":"79","author":"Shipounova","year":"2014","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.eclinm.2019.100249_bib0042","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1007\/s10529-014-1589-z","article-title":"The beneficial effects of intracoronary autologous bone marrow stem cell transfer as an adjunct to percutaneous coronary intervention in patients with acute myocardial infarction","volume":"36","author":"Wang","year":"2014","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.eclinm.2019.100249_bib0043","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1111\/jgh.12653","article-title":"Randomized trial of autologous bone marrow mesenchymal stem cells transplantation for hepatitis B virus cirrhosis: regulation of Treg\/Th17 cells","volume":"29","author":"Xu","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.eclinm.2019.100249_bib0044","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.4238\/2015.April.10.11","article-title":"Clinical observation of umbilical cord mesenchymal stem cell treatment of severe systolic heart failure","volume":"14","author":"Zhao","year":"2015","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.eclinm.2019.100249_bib0045","article-title":"BM-MSC accelerates acute stroke recovery in a randomized placebo-controlled clinical phase II\/III study","volume":"18","author":"Ibrahim","year":"2016","journal-title":"Cytotherapy"},{"key":"10.1016\/j.eclinm.2019.100249_bib0046","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1200\/JCO.2015.65.3642","article-title":"Phase ii multicenter, randomized, double-blind controlled study of efficacy and safety of umbilical cord-derived mesenchymal stromal cells in the prophylaxis of chronic graft-versus-host disease after HLA-Haploidentical stem-cell transplantation","volume":"34","author":"Gao","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eclinm.2019.100249_bib0047","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1002\/hep.28693","article-title":"Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: phase 2 trial","volume":"64","author":"Suk","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.eclinm.2019.100249_bib0048","first-page":"3241","article-title":"Therapeutic effects of human umbilical cord mesenchymal stem cells transplantation on hypoxic ischemic encephalopathy","volume":"8","author":"Xie","year":"2016","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.eclinm.2019.100249_bib0049","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/CIRCRESAHA.117.310712","volume":"121","author":"Bartolucci","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.eclinm.2019.100249_bib0050","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.3892\/etm.2016.3544","article-title":"Long term effect and safety of wharton's jelly-derived mesenchymal stem cells on type 2 diabetes","volume":"12","author":"Hu","year":"2016","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.eclinm.2019.100249_bib0051","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.3892\/etm.2016.3724","article-title":"Safety and therapeutic effect of mesenchymal stem cell infusion on moderate to severe ulcerative colitis","volume":"12","author":"Hu","year":"2016","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.eclinm.2019.100249_bib0052","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1136\/annrheumdis-2017-211073","article-title":"A randomised double-blind, placebo-controlled trial of allogeneic umbilical cord-derived mesenchymal stem cell for lupus nephritis","volume":"76","author":"Deng","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.eclinm.2019.100249_bib0053","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.29189","article-title":"Allogeneic bone marrow-derived mesenchymal stromal cells for hepatitis B virus-related acute-on-chronic liver failure: a randomized controlled trial","volume":"66","author":"Lin","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.eclinm.2019.100249_bib0054","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1002\/sctm.17-0134","article-title":"A pilot study of mesenchymal stem cell therapy for acute liver allograft rejection","volume":"6","author":"Shi","year":"2017","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.eclinm.2019.100249_bib0055","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1681\/ASN.2016101150","article-title":"Allogeneic mesenchymal stem cells for treatment of AKI after cardiac surgery","volume":"29","author":"Swaminathan","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.eclinm.2019.100249_bib0056","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1093\/gerona\/glx137","article-title":"Allogeneic mesenchymal stem cells ameliorate aging frailty: a phase II randomized, double-blind, placebo-controlled clinical trial","volume":"72","author":"Tompkins","year":"2017","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.eclinm.2019.100249_bib0057","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4252\/wjsc.v9.i8.133","article-title":"Phase I\/Ii randomized controlled trial of autologous bone marrow-derived mesenchymal stem cell therapy for chronic stroke","volume":"9","author":"Tsang","year":"2017","journal-title":"World J Stem Cells"},{"key":"10.1016\/j.eclinm.2019.100249_bib0058","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1536\/ihj.16-328","article-title":"A randomized comparative study on the efficacy of intracoronary infusion of autologous bone marrow mononuclear cells and mesenchymal stem cells in patients with dilated cardiomyopathy","volume":"58","author":"Xiao","year":"2017","journal-title":"Int Heart J"},{"key":"10.1016\/j.eclinm.2019.100249_bib0059","doi-asserted-by":"crossref","DOI":"10.4238\/gmr16019352","article-title":"A clinical study of bone mesenchymal stem cells for the treatment of hepatic fibrosis induced by hepatolenticular degeneration","volume":"16","author":"Zhang","year":"2017","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.eclinm.2019.100249_bib0060","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5009\/gnl17035","article-title":"Umbilical cord mesenchymal stem cell treatment for crohn's disease: a randomized controlled clinical trial","volume":"12","author":"Zhang","year":"2018","journal-title":"Gut Liver"},{"key":"10.1016\/j.eclinm.2019.100249_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcyt.2017.03.059","article-title":"Efficacy of autologous expanded bone marrow derived mesenchymal stem cells (axBM-MSC) in the treatment of patients with chron's disease who have failed to standard therapy: an open-label, randomized controlled clinical trial phase II","volume":"19","author":"Arturo","year":"2017","journal-title":"Cytotherapy"},{"key":"10.1016\/j.eclinm.2019.100249_bib0062","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195891","article-title":"Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: a triple blinded, placebo controlled, randomized phase I\/II safety and feasibility study","volume":"13","author":"Fernandez","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.eclinm.2019.100249_bib0063","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12967-018-1422-x","article-title":"Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trial","volume":"16","author":"Sun","year":"2018","journal-title":"J Transl Med"},{"key":"10.1016\/j.eclinm.2019.100249_bib0064","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjx002.008","article-title":"OP009 long-term efficacy and safety of Cx601, allogeneic expanded adipose-derived mesenchymal stem cells, for complex perianal fistulas in Crohn's disease: 52-week results of a phase III randomised controlled trial","volume":"11","author":"Panes","year":"2017","journal-title":"J Crohn's Colitis"},{"key":"10.1016\/j.eclinm.2019.100249_bib0065","volume":"49","author":"Kim","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.eclinm.2019.100249_bib0066","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/scrt459","article-title":"Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease","volume":"5","author":"Salama","year":"2014","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.eclinm.2019.100249_bib0067","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.1097\/01.tp.0000542862.31279.24","article-title":"The results of pilot study of the mesenchymal stem cells efficiency for induction of immunosuppressive therapy in the early postoperative period after kidney transplantation","volume":"102","author":"Korotkov","year":"2018","journal-title":"Transpl"},{"key":"10.1016\/j.eclinm.2019.100249_bib0068","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S2213-2600(18)30418-1","article-title":"Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial","volume":"7","author":"Matthay","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.eclinm.2019.100249_bib0069","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.msard.2014.08.002","article-title":"Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: a randomized, placebo-controlled, multiple-dose study","volume":"3","author":"Lublin","year":"2014","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.eclinm.2019.100249_bib0070","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1097\/MIB.0000000000000441","article-title":"Human placenta-derived cells (PDA-001) for the treatment of moderate-to-severe crohn's disease: a phase 1b\/2a study","volume":"21","author":"Melmed","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.eclinm.2019.100249_bib0071","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/968213","article-title":"Multipotent mesenchymal stromal cells for the prophylaxis of acute graft-versus-host disease-a phase II study","volume":"2012","author":"Kuzmina","year":"2012","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.eclinm.2019.100249_bib0072","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12967-018-1541-4","article-title":"Serum IFN-gamma levels predict the therapeutic effect of mesenchymal stem cell transplantation in active rheumatoid arthritis","volume":"16","author":"Yang","year":"2018","journal-title":"J Transl Med"}],"container-title":["EClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537019302585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537019302585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T19:01:20Z","timestamp":1762887680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537019302585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":72,"alternative-id":["S2589537019302585"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2019.100249","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"EClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2019.100249","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100249"}}